Elanco Animal Health Incorporated Proceeds from Hedge, Investing Activities
Elanco Animal Health Incorporated (ELAN) reported Proceeds from Hedge, Investing Activities of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromHedgeInvestingActivities · last filed 2021-11-05
- Elanco Animal Health Incorporated proceeds from hedge, investing activities for the quarter ending 2021-09-30 was $0.00.
- Elanco Animal Health Incorporated proceeds from hedge, investing activities for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Elanco Animal Health Incorporated proceeds from hedge, investing activities for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Elanco Animal Health Incorporated proceeds from hedge, investing activities for the quarter ending 2020-12-31 was -$300.00K.
- Elanco Animal Health Incorporated proceeds from hedge, investing activities for fiscal 2020 was $32.70M.
- Elanco Animal Health Incorporated proceeds from hedge, investing activities for fiscal 2019 was $0.00.
- Elanco Animal Health Incorporated proceeds from hedge, investing activities for fiscal 2018 was $0.00.
| Period end | Proceeds from Hedge, Investing Activities 3 month | Proceeds from Hedge, Investing Activities 3 month as first filed | Proceeds from Hedge, Investing Activities 6 month | Proceeds from Hedge, Investing Activities 6 month as first filed | Proceeds from Hedge, Investing Activities 9 month | Proceeds from Hedge, Investing Activities 9 month as first filed | Proceeds from Hedge, Investing Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $0.00 10-Q · filed 2021-11-05 | -$300.00K derived: sum of 4 quarters · filed 2021-11-05 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | -$300.00K derived: sum of 3 quarters · filed 2021-08-09 | -$300.00K derived: sum of 4 quarters · filed 2021-11-05 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | -$300.00K derived: sum of 2 quarters · filed 2021-05-07 | -$300.00K derived: sum of 3 quarters · filed 2021-11-05 | $7.70M derived: sum of 4 quarters · filed 2021-11-05 | |||
| 2020-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$300.00K derived: sum of 2 quarters · filed 2021-11-05 | $7.70M derived: sum of 3 quarters · filed 2021-11-05 | $32.70M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $8.00M derived: sum of 2 quarters · filed 2021-11-05 | $33.00M 10-Q · filed 2021-11-05 | $32.70M 10-Q · filed 2020-11-06 | $33.00M derived: sum of 4 quarters · filed 2021-11-05 | ||
| 2020-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $33.00M 10-Q · filed 2021-08-09 | $32.70M 10-Q · filed 2020-07-30 | $33.00M derived: sum of 3 quarters · filed 2021-08-09 | $33.00M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $25.00M 10-Q · filed 2021-05-07 | $25.20M 10-Q · filed 2020-05-07 | $25.00M derived: sum of 2 quarters · filed 2021-05-07 | $25.00M derived: sum of 3 quarters · filed 2021-05-07 | $25.00M derived: sum of 4 quarters · filed 2021-05-07 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 | |||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | ||||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |